Skip to main content
. 2015 Feb 13;12:17. doi: 10.1186/s12977-015-0142-z

Table 3.

Above-background cytokine responses to αGalCer at 5 days post-stimulation

Analyte HIV-negative (n = 14) HIV+ ART naïve (n = 8) HIV+ ART experienced (n = 14) p value ** Post-test differences ***
IFNγ N Detectible 13 7 8 0.057
Concentration* 345.9 (76.74, 2115) 34.97 (4.83, 142.7) 2.275, (0.0, 124.8) 0.003 HIV-N vs HIV+ ART
IL-4 N Detectible 7 3 2 0.129
Concentration* 3.06 (0.0, 22.02) 0.0 (0.0, 6.69) 0.0 (0.0, 0.18) 0.095
IL-10 N Detectible 4 2 6 0.618
Concentration* 0.0 (0.0, 5.82) 0.0 (0.0, 4.25) 0.0 (0.0, 13.8) 0.683
IL-13 N Detectible 11 5 6 0.152
Concentration* 199.1 (19.23, 477.0) 8.26 (0.11, 77.2) 0.0 (0.0, 25.45) 0.014 HIV-N vs HIV+ ART
IP-10 N Detectible 11 6 5 0.005
Concentration* 1586 (836.8, 6168) 329.3 (24.5, 5351) 0.0 (0.0, 409.6) 0.001 HIV-N vs HIV+ ART
MIP-1α N Detectible 6 4 4 0.409
Concentration* 0.0 (0.0, 198.4) 37.2 (0.0, 158.5) 0.0 (0.0, 75.6) 0.453
MIP-1β N Detectible 8 4 4 0.368
Concentration* 78.16 (0.0, 370.2) 35.06 (0.0, 165.1) 0.0 (0.0, 104.6) 0.253
TNFα N Detectible 10 7 6 0.084
Concentration* 52.34 (0.0, 317.1) 20.2 (4.74, 115.1) 0.065 (0.0, 140.2) 0.370

*Data are presented as median (IQR) in pg/mL.

**p values obtained from Chi squared tests for N detectible data, Kruskal-Wallis tests for concentration comparisons.

***Dunn’s post-test comparisons with p < 0.05 are indicated for each significant Kruskal-Wallis result Statistical tests with p ≤ 0.1 (trend) are indicated in bold.